Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we’ll explain below. However, now that it’s down 76% from highs, ...

As CEO of InMode, I felt it was important to wait until after our earnings call on February 4, 2025, to respond comprehensively to the concerns raised in your recent communications. Over the past year ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

InMode is a leader in the niche industry of minimally invasive medical treatment solutions, with strong brand recognition and a growing market presence. The company has an experienced leadership team, ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

InMode (NASDAQ:INMD) shares fell roughly 8% on Tuesday after the medical devices company announced the departure of ...

On Wednesday, 04 June 2025, InMode Ltd (NASDAQ:INMD) participated in the Jefferies Global Healthcare Conference 2025, offering insights into its strategic direction amid challenging economic ...

In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode (NASDAQ: INMD) more than doubled as enthusiasm for all things new and ...

InMode Ltd INMD shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings forecast. InMode noted that its proprietary surgical technology ...

InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ...